Evidence should move slower than enthusiasm.
Brainwavest separates a working signal engine, a usable product, listener-reported experience, and controlled efficacy. Each is valuable. They are not interchangeable.
Signal verification
Automated checks prove the published carrier, trajectory, mode, envelope, noise, timing, and safety bounds match the generated Core specification. This verifies implementation—not an outcome.
Usability and preference
Anonymous activation, completion, return, and fit totals show whether people can choose, start, finish, and return. Local fit answers personalize Today without creating a person-level analytics record.
Observational outcomes
A consented cohort with preregistered questions, baseline measures, attrition reporting, and adverse-event capture is required before Brainwavest publishes outcome language.
Controlled efficacy
A comparator, sufficient sample, preregistered endpoints, statistical plan, and independent or clearly disclosed analysis are required. Marketing cannot promote this level before the study exists.
Publication rules
- Define the claim before collecting data.
- Publish inclusion, exclusion, sample size, comparator, endpoints, and limitations.
- Separate preference from performance, and mechanism from outcome.
- Report null findings, attrition, conflicts, and adverse experiences.
- Never turn aggregate product analytics into medical evidence.